Abiopharma

🔍 Clinton Chelsea (Director)

Company: Expedia Group, Inc. (EXPE)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 56 shares of Stock Units (Derivative)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 2,886.95 | transaction_form_type: 4 | Footnotes: F1, F2, F3, F3

Footnotes:

• F1: Stock units are convertible into common stock on a 1-for-1 basis.
• F2: Represents (as rounded) 50.078 stock units accrued under the Expedia Group, Inc. Non-Employee Director Deferred Compensation Plan (the "Plan") in lieu of director cash compensation for the quarter ended March 31, 2026 and 5.836 stock units accrued under the Plan in connection with a dividend paid by Expedia Group, Inc. during the quarter ended March 31, 2026.
• F3: Stock units under the Expedia Group, Inc. Non-Employee Director Deferred Compensation Plan are to be settled in shares of common stock of Expedia Group, Inc. after the reporting person's termination of services as a director.